Table 1

Clinical characteristics of 916 study participants

WomenMen
n501415
Age (years)59 ± 959 ± 9
BMI (kg/m2)27.8 ± 5.328.8 ± 4.4
Waist circumference (inches)38 ± 641 ± 4
Obesity (%)28.129.4
Triglycerides (mg/dl)109 (77–163)116 (77–174)
HDL cholesterol (mg/dl)61 ± 1646 ± 12
Total cholesterol (mg/dl)206 ± 36195 ± 33
Dyslipidemia treatment (%)14.415.2
Systolic blood pressure (mmHg)124 ± 20127 ± 16
Hypertension (%)36.140.0
Hypertension treatment (%)26.426.3
Fasting plasma glucose (mg/dl)98 ± 17105 ± 24
Diabetes (%)7.210.8
Metabolic syndrome (%)38.341.9
Physical activity index37.438.2
Smoking (%)
    Current41.539.3
    Former47.751.1
    Never10.814.9
Alcohol use (%)*16.014.9
Postmenopausal (%)81.6
Hormone replacement therapy (%)36.9
CT fat measures (cm3)
    Visceral fat1,627 ± 8692,539 ± 1,045
    Subcutaneous fat3,350 ± 1,3782,676 ± 1,124
    Pericardial fat109 ± 40135 ± 51
    Intrathoracic fat85 ± 43146 ± 63
Adiponectin (μg/ml)11.0 (7.6–16.5)6.3 (4.2–9.0)
Resistin (ng/ml)13.1 (10.5–16.3)13.0 (10.3–17.0)
  • Data are means ± SD or median (25th–75th percentile).

  • *Defined as ≥7 drinks/week (for women) or ≥14 drinks/week (for men). Conversion to SI units: multiply waist circumference by 2.54 for cm, triglycerides by 0.01129 for mmol/l, HDL and total cholesterol by 0.02586 for mmol/l, and fasting plasma glucose by 0.05551 for mmol/l.